China (Mainland)
Premiumsupplier
Lorcaserin Hydrochloride Powder 616202-92-7 For Weight Loss CAS NO.616202-92-7
- FOB Price: USD: 16.00-20.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/P,T/T,MoneyGram
- Available Specifications:
99%一级(1-10)Kilogram99%一级(11-50)Kilogram99%一级(51-200)Kilogram
- Product Details
Keywords
- 856681-05-5 99% Lorcaserin supplier in China
- Sell high quility Lorcaserin Hydrochloride 616202-92-7
- Lorcaserin 856681-05-5 in China
Quick Details
- ProName: Lorcaserin Hydrochloride Powder 616202...
- CasNo: 616202-92-7
- Molecular Formula: 195.6886
- Appearance: white powder
- Application: used in the production of medicine suc...
- DeliveryTime: Within 3-7 days after receipt of your ...
- PackAge: As customer request
- Port: Qingdao,China
- ProductionCapacity: 100 Kilogram/Day
- Purity: 99%
- Storage: Store in a cool,dry place and keep awa...
- Transportation: By Sea/Air/Courier
- LimitNum: 1 Kilogram
- Moisture Content: <0.02
- Impurity: <0.02
Superiority
lorcaserin(616202-92-7) is medicine reducing weight and antidepressants
Details
Cas numbers :616202-92-7
Molecular formula: c11h14cln
Molecular weight 195.6886
Assay 99%
Boiling point 288.125°c at 760 mmhg
Flash point 128.054°c
Appearance white crystal powder
Product usage:medicine reducing weight and antidepressants.
|
items |
standard |
results |
|
description |
white to kind of white powder |
kind of white powder |
|
melting point |
193.0-200 |
196.0-198.9 |
|
water |
5-6.5% |
5.6% |
|
solubility |
soluble in methanol |
complies |
|
ph |
4.0-6.0 |
5 |
|
heavy metals |
≤10ppm |
complies |
|
assay |
≥96% |
99.5% |
|
residue on ignition |
≤0.1% |
0.03% |
|
single impurity |
≤0.2% |
0.19% |
|
conclusion |
up to the standard usp 32. |
|
Obesity has become a worldwide problem since the extra weight can increase the risk of hypertension, diabetes, hyperlipidemia, stroke, heart disease, and osteoarthritis. Lorcaserin(616202-92-7)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Obesity has become a worldwide problem since the extra weight can increase the risk of hypertension, diabetes, hyperlipidemia, stroke, heart disease, and osteoarthritis. Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
